OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Curcumin inhibits pancreatic cancer cell proliferation by regulating Beclin1 expression and inhibiting the hypoxia-inducible factor-1α-mediated glycolytic pathway
Guo Wen-cheng, Yamei Ding, Chunmei Pu, et al.
Journal of Gastrointestinal Oncology (2022) Vol. 13, Iss. 6, pp. 3254-3262
Open Access | Times Cited: 13

Showing 13 citing articles:

The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug delivery
Mohamed J. Saadh, Hala Baher, Yuanji Li, et al.
Environmental Research (2023) Vol. 233, pp. 116490-116490
Closed Access | Times Cited: 29

Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches
Ming Gu, Yang Liu, Xin Peng, et al.
Cancer Letters (2024) Vol. 588, pp. 216738-216738
Closed Access | Times Cited: 6

Natural Compounds for Preventing Age-Related Diseases and Cancers
Mi‐Ran Ki, Sol Youn, Dong Hyun Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7530-7530
Open Access | Times Cited: 6

Potential Applications of the Anti-Inflammatory, Antithrombotic and Antioxidant Health-Promoting Properties of Curcumin: A Critical Review
Elli Rapti, Theodora Adamantidi, Pavlos Efthymiopoulos, et al.
Nutraceuticals (2024) Vol. 4, Iss. 4, pp. 562-595
Open Access | Times Cited: 6

Insights into curcumin’s anticancer activity in pancreatic ductal adenocarcinoma: Experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1
Jun‐Feng Cao, Xiao Zhang, Qingjie Xia, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108264-108264
Closed Access

Therapeutic Approaches in Pancreatic Cancer: Recent Updates
Lokender Kumar, Sanjay Kumar, Sandeep Kumar, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1611-1611
Open Access | Times Cited: 14

The Ubiquitin–Proteasome System in Tumor Metabolism
Jie Wang, Yuandi Xiang, Mengqi Fan, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2385-2385
Open Access | Times Cited: 12

The Effect Of Curcumin On Hypoxia In Tumor Microenvironment As a Regulatory Factor In Cancer
Mohammad Zahedi, Hanieh Salmani Izadi, Faezeh Arghidash, et al.
Archives of Medical Science (2023)
Open Access | Times Cited: 5

Curcumin Inhibits the PPARδ-p-Akt-GLUT1 Pathway and Ameliorates the Antiproliferative Effects of Doxorubicin in MDA-MB-231 Cells
Padmamalini Thulasiraman, Marie Foret, Renu Pandit, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 3, pp. 1035-1043
Open Access

Possible Combinatorial Utilization of Phytochemicals and Extracellular Vesicles for Wound Healing and Regeneration
Sachiko Koyama, Erin L. Weber, Thomas Heinbockel
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10353-10353
Open Access

Rs1347093 regulates microRNA-216/-217 expression and is associated with pancreatic cancer risk
Hsin-Hung Huang, Tzu‐Yue Shiu, De-Chuan Chan, et al.
Pancreatology (2024)
Closed Access

Curcumin relieves arecoline‐induced oral submucous fibrosis via inhibiting the LTBP2/NF‐κB axis
Lin Zhang, Jin Tan, Yiping Liu, et al.
Oral Diseases (2023) Vol. 30, Iss. 4, pp. 2314-2324
Closed Access | Times Cited: 1

Page 1

Scroll to top